A retrospective cohort study comparing thick and thin liquid diets for patients with Alzheimer disease and related dementias (ADRD) and dysphagia yielded mixed results.
In his PUPC 2024 session, "Gastroesophageal Reflux Disease: An Evidence-Based Update", Dr Heidelbaugh presented an evidence-based approach to the diagnostic and treatment options for gastroesophageal reflux...
In his PUPC 2024 session, "Using the Most Recent Safe Opioid Prescribing and Alternative Therapy Guidelines in Primary Care" Dr Hudspeth provided an overview of the national guidelines for managing pain...
In this video, Linda Davis, MD, provides a review of her session, "Empowering the Patient: Shared Clinical Decision Making and Advocating for the Patient" at Practical Updates in Primary Care. In her...
Researchers examined the epidemiology of hydroxymethylbilane synthase (HMBS) gene defects and activity levels among patients with acute intermittent porphyria to better understand the role of HMBS activity...
This COVID-19 roundup includes coverage on the latest estimated number of adults with long COVID, WHO’s updated terminology for pathogens that transmit through the air, how COVID-19 vaccination reduces the...
Researchers evaluated the safety and efficacy of dextromethorphan-bupropion, an FDA approved treatment of major depression disorder, for Alzheimer disease-related agitation. This study was presented at the...
Researchers collected data from the Atherosclerosis Risk in Communities Study to determine whether heart rate variability was associated with agitation risk in individuals clinically diagnosed with dementia...
